Name: PHI’s CEO comments on the approved US listing
Uploaded: 2024-08-21T08:15:33+02:00
Channel: BioStock
Description: Phase Holographic Imaging's CEO Patrik Eschrich comments the approved dual US listing and the upcoming redemption of the TO4 warrants.

PHI’s CEO comments on the approved US listing

21 August, 2024

Shift to regenerative medicine increases growth prospects for PHI

20 March, 2024

Tag: Ivan Jurkovic

PHI’s CEO comments on the approved US listing

Shift to regenerative medicine increases growth prospects for PHI